Scientific Sessions 2024  /  Substance Use and Cardiovascular Risk 1  /  The Effects of Illicit Drug Use on Congestive Heart Failure Patients and Hospital Readmission Rates at Harlem Hospital Center
Logo

American Heart Association

  161
  0

Final ID: Sa3141

The Effects of Illicit Drug Use on Congestive Heart Failure Patients and Hospital Readmission Rates at Harlem Hospital Center

Abstract Body (Do not enter title and authors here): Introduction: CHF is defined as a chronic disease that impacts more than 5 million adults in the United States with significant population-wide impact on morbidity, mortality and hospitalization burden, especially amonth high-risk and vulnerable populations. Although the intricacies of CHF and readmission risk have been well documented, there have been fewer studies investigating the effect of illicit drug use on CHF patients and readmission outcomes especially in a population at high risk of health disparities.
Objective: The purpose of this study was to examine the effects of illicit drug use on CHF patients and hospital readmission rates at Harlem Hospital Center with a high density of patients with health disparities.
Methods: We included all patients admitted during a 2 year period (2019-2020) with a primary diagnosis of heart failure to Harlem Hospital Center and conducted in depth assessment of drug use history including patient history, available laboratory analysis, and collateral EMR information. Rehospitalization was assessed by review of EMR by trained medical professionals. Our results were analyzed using standard statistical methods between the two groups with and without history of drug use.
Results: Our study population included 380 admitted CHF patients. The overall prevalence of illicit drug use in CHF patients was 32.89%, with the most common drug used being cocaine. CHF patients who used illicit drugs had a 22.58% 30-day readmission rate in comparison to 13.78% among CHF patients who didn’t use illicit drugs. In addition, CHF patients who used illicit drugs had higher all-time hospitalizations and were more likely to be admitted than non-illicit drug users in terms of heart failure hospitalizations. Overall, CHF patients who used any type of illicit drug were twice as likely to be readmitted after index hospitalization compared to CHF patients who didn’t use illicit drugs. We also found that CHF patients who used illicit drugs were slightly younger, more likely to be male, and more likely to smoke cigarettes. Lastly, we observed that at least 50% of CHF patients who used illicit drugs were on government assistance, lacked family support, and were unemployed.
Conclusion: Drug use is a common problem among patients with CHF in this vulnerable population and is associated with significant adverse outcomes such as increased rehospitalization. Systemic efforts to address this at the patient and community level are justified.
  • Majdalani, Rosemarie  ( Institute of Human Nutrition , New York , New York , United States )
  • Magdits, Mariel  ( UCSF , San Francisco , California , United States )
  • Alshammari, Asmaa  ( Institute of Human Nutrition , New York , New York , United States )
  • Hughes, Anna  ( Institute of Human Nutrition , New York , New York , United States )
  • Mccann, Lily  ( Institute of Human Nutrition , New York , New York , United States )
  • Devarajan, Sriraman  ( Harlem Hospital Center , New York , New York , United States )
  • Thu, Myint  ( Harlem Hospital Center , New York , New York , United States )
  • Jameel, Ihab  ( Harlem Hospital Center , New York , New York , United States )
  • Mangeshkar, Shaunak  ( Harlem Hospital Center , New York , New York , United States )
  • Kwentoh, Ifeoma  ( Harlem Hospital Center , New York , New York , United States )
  • Roy, Pooja  ( Harlem Hospital Center , New York , New York , United States )
  • Dulal, Subash  ( Harlem Hospital Center , New York , New York , United States )
  • Jha, Sapana  ( Harlem Hospital Center , New York , New York , United States )
  • Shou, Jialu  ( Institute of Human Nutrition , New York , New York , United States )
  • Rijhwani, Simran  ( Institute of Human Nutrition , New York , New York , United States )
  • Ionescu, Natalia  ( Harlem Hospital Center , New York , New York , United States )
  • Kakade, Meghana  ( Harlem Hospital Center , New York , New York , United States )
  • Kurian, Damian  ( Harlem Hospital Center , New York , New York , United States )
  • Raiszadeh, Farbod  ( Harlem Hospital Center , New York , New York , United States )
    • Author Disclosures:
    Rosemarie Majdalani: DO NOT have relevant financial relationships | Ifeoma Kwentoh: No Answer | Pooja Roy: DO NOT have relevant financial relationships | Subash Dulal: No Answer | Sapana Jha: No Answer | Jialu Shou: No Answer | Simran Rijhwani: DO NOT have relevant financial relationships | Natalia Ionescu: No Answer | Meghana Kakade: No Answer | Damian Kurian: No Answer | Farbod Raiszadeh: DO NOT have relevant financial relationships | Mariel Magdits: DO NOT have relevant financial relationships | Asmaa Alshammari: DO NOT have relevant financial relationships | Anna Hughes: No Answer | Lily McCann: DO NOT have relevant financial relationships | Sriraman Devarajan: No Answer | Myint Thu: No Answer | Ihab Jameel: No Answer | Shaunak Mangeshkar: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Substance Use and Cardiovascular Risk 1

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
A Novel CRISPR based Epigenetic Silencer Potently, Durably, and Safely Reduces LDLc in Non-Human Primates at Therapeutically Relevant Doses

Duncan-lewis Christopher, Narsineni Lokesh, Karmarkar Maitreyee, Li Yuexuan, Krupa Oleh, Bucher Simon, Sharma Neel, Chang Han, Schulwach Keith, Ripley-phipps Sterling, Tran Vanessa, Fernandes Jason, Goh Natalie, Deiter Fred, Reimer Kirsten, Mrak Anna, Eggers Michelle, Sze Christie, Mirotsou Maria, Oresic Bender Kristina, Bardai Farah, Denny Sarah, Charles Emeric, Khakoo Aarif, Oakes Benjamin, Keller Steven, Alcantara-lee Raniel, Santamaria Carlos, Bale Shyam Sundhar, Kozy Heather, Corbo Lana

A Multi-Center Clinic Site Comparison of Patient-level factors Affecting Oral Anticoagulation Prescription for Atrial Fibrillation

Iqbal Fatima, Hoang Kenneth, Chiadika Simbo

More abstracts from these authors:
The Obesity Paradox in Heart Failure: Exploring the Impact of BMI on 30-Day Readmission Rates in a Community Safety-Net Hospital

Alshammari Asmaa, Rijhwani Simran, Thearle Marie, Shou Jialu, Thu Myint, Mangeshkar Shaunak, Majdalani Rosemarie, Raiszadeh Farbod

Diagnostic Performance of the ATTR-CM Mayo Score in Black and Hispanic individuals: Findings from SCAN-MP

Barrera Nelson, Ruberg Frederick, Miller Edward, Maurer Mathew, Teruya Sergio, Helmke Stephen, Alreshq Rabah, Fine Denise, Ullah Ikram, Raiszadeh Farbod, Ionescu Natalia, Gallegos Cesia

You have to be authorized to contact abstract author. Please, Login
Not Available